U.S., March 25 -- ClinicalTrials.gov registry received information related to the study (NCT06892392) titled 'Application of Indocyanine Green Tracer in D2 Lymphadenectomy of Locally Advanced Gastric Cancer' on March 10.
Brief Summary: Gastric cancer is a frequent neoplasm in the world, presenting more than one million new cases and around 768,000 deaths in the data registered in 2020. Among the therapeutic options for gastric cancer, surgery is an essential pillar for its treatment. Gastric cancer surgery consists of gastric resection with negative margins and radical lymphadenectomy in patients without distant metastases. It has been demonstrated over the years that radical lymphadenectomy in gastric cancer allows for adequate staging an...